Daniel Shore

Daniel Shore has extensive experience in the field of medicinal chemistry, currently serving as a Senior Scientist at ORIC Pharmaceuticals Inc. since April 2021, following a position as a Scientist in the same department. Prior roles include Senior Research Associate II at Gilead Sciences from May 2019 to March 2021, and a decade-long tenure at Genentech from August 2009 to April 2019 encompassing various roles, including Senior Scientific Researcher and Research Associate in Discovery Chemistry. Earlier experience also includes a summer internship at Merck-Frosst in 2007. Academic credentials include a Master’s degree in Organic Chemistry and a Bachelor’s degree in Chemistry, both obtained from the University of Ottawa.